Taiwan’s CPDC runs Kaohsiung capro line at 80%; Toufen line shut

22 April 2013 10:39  [Source: ICIS news]

BRISBANE (ICIS)--China Petrochemical Development Corp (CPDC) is running its 200,000 tonne/year caprolactam (capro) line at Kaohsiung at 80% of capacity amid weak demand, while its Toufen unit is currently undergoing maintenance, a company source said on Monday.

The 100,000 tonne/year line in Toufen was taken off line around mid-April and is expected to resume operations in mid-May, the source said.

The shutdown, which was
brought forward from end-April, may be prolonged to end-May if market conditions failed to improve, the source said.

CPDC - the sole capro producer in Taiwan - has a second 100,000 tonne/year capro line at Toufen that has yet to begin operation.

By: Junie Lin

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly